An Guo Wang

Dr. An Guo Wang

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2006 in Japanese Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
YLYen-Ching Lin
Yen-Ching Lin
MYMay-Yung Yen
May-Yung Yen
WHWen-Ming Hsu
Wen-Ming Hsu
HLHui-Chen Lee
Hui-Chen Lee
AWAn Guo Wang
An Guo Wang

14 October 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CLChia-Wei Lee
Chia-Wei Lee
HCHui-Chen Cheng
Hui-Chen Cheng
FCFeng-Chi Chang
Feng-Chi Chang
AWAn Guo Wang
An Guo Wang
The aim of the study was to evaluate the influence of carotid angioplasty and stenting (CAS) on retinal microvasculature using optical coherence tomography angiography (OCTA) in patients with severe carotid stenosis. 20 patients with severe carotid stenosis underwent comprehensive ophthalmic examinations and OCTA before and one month after CAS. Automated algorithms were used to quantify vessel density in the macular superficial vascular complex (SVC), deep vascular complex (DVC), and radial peripapillary capillary (RPC) around the optic disc. Eyes on the operated side constituted the ipsilateral eye group, and the other eye constituted the fellow eye group. In the ipsilateral eye group, the vessel density in the DVC increased significantly after stent implantation (P = 0.010), but the vessel density change in the SVC was not statistically different (P = 0.999). In the fellow eye group, the vessel density in the SVC (P = 0.028) and DVC (P = 0.034) were significantly increased after stent implantation. The vessel density in the RPC did not significantly change in the ipsilateral (P = 0.363) or fellow (P = 0.878) eye groups. This study shows that unilateral CAS for severe carotid stenosis increases macular vessel densities in both eyes.

1 January 2014 in Clinical and Experimental Optometry
Verified
Journal Article
Closed access
PDF file
THTsui‐Kang Hsu
Tsui‐Kang Hsu
AWAn Guo Wang
An Guo Wang
MYMay‐Yung Yen
May‐Yung Yen
JLJorn‐Hon Liu
Jorn‐Hon Liu

1 December 2016 in Ophthalmology
Verified
Journal Article
Closed access
HCHui-Chen Cheng
Hui-Chen Cheng
RPRen-Hao Pan
Ren-Hao Pan
HYHuan-Jui Yeh
Huan-Jui Yeh
KLK. Robert Lai
K. Robert Lai
MYMay-Yung Yen
May-Yung Yen
AWAn Guo Wang
An Guo Wang

1 December 2015 in Ophthalmology
Verified
Journal Article
Closed access
HCHui-Chen Cheng
Hui-Chen Cheng
HYHuan-Jui Yeh
Huan-Jui Yeh
NHNicole Huang
Nicole Huang
YCYiing-Jenq Chou
Yiing-Jenq Chou
MYMay-Yung Yen
May-Yung Yen
AWAn Guo Wang
An Guo Wang

18 November 2016 in Neuro-Ophthalmology
Verified
Journal Article
Closed access
AWAn Guo Wang
An Guo Wang
HCHui-Chen Cheng
Hui-Chen Cheng
Amiodarone, an antiarrhythmic agent, has been associated with visual loss secondary to optic neuropathy. The reported mean duration of amiodarone use before visual loss is about 9 months. Patients receiving amiodarone have a 2-fold increased risk of developing optic neuropathy, especially in males and possibly in patients with longer duration of treatment. Amiodarone-associated optic neuropathy is characterised by an insidious onset, slow progression, bilateral simultaneous visual loss, and protracted disc swelling. After discontinuing amiodarone use, visual acuity and visual field deficits tend to improve or stabilise in most patients, with about 20% of the patients getting worse.